Last updated 2026-07-26
Total raised
—
Last: Undisclosed Round 2024-02
Stage
Series A
Founded
2015
Headcount
12
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences
About
Betalin Therapeutics is a biotech company specializing in tissue engineering for curing diabetes. The company is developing an Engineered Micro Pancreas (EMP), a novel technology that aims to provide significant levels of glucose-regulated insulin secretion over extended periods. This approach uses a biological scaffold to support insulin-producing beta cells, mimicking their natural environment to ensure long-term survival and function, with the goal of eliminating the need for daily insulin injections for patients with Type 1 and severe Type 2 diabetes.
Headcount over time
12 employees (2026-09) · 1 point
Offices
Jerusalem, Israel · HQ / main office
Show all offices (1 more)
- Ramat Gan, Israel
Q&A
- What is Betalin Therapeutics' primary focus?
- Betalin Therapeutics is a biotech company specializing in tissue engineering for curing diabetes, developing an Engineered Micro Pancreas (EMP) to provide glucose-regulated insulin secretion.
- When was Betalin Therapeutics founded?
- Betalin Therapeutics was founded in 2015.
- What is the current employee count for Betalin Therapeutics?
- Betalin Therapeutics has 1-10 employees.
- What was Betalin Therapeutics' most recent funding round?
- In February 2024, Betalin Therapeutics received a grant from Together We Invest.
- What was Betalin Therapeutics' most recent equity funding round?
- In February 2022, Betalin Therapeutics closed an A Round, with the.
- What is the total amount of funding Betalin Therapeutics has raised to date?
- Betalin Therapeutics has raised a total of $15,100,285 USD.
- What is the product stage of Betalin Therapeutics' technology?
- Betalin Therapeutics' product is currently in the clinical trial stage.
- Who are the co-founders of Betalin Therapeutics?
- The co-founders of Betalin Therapeutics are Shuki Joshua Hershcovich, Shay Hershcovich, and Eduardo Mitrani.
Team · 14
Shuki Joshua Hershcovich
Founder · Co-Founder
Shay Hershcovich
Founder · Co-Founder
Eduardo Mitrani
Founder · Inventor and Founder, Head of Scientific Advisory Board
Racheli Ofir
CEO & CTO
Moti Friedman
CEO
Nikolai Kunicher
CEO
Sharona Even Ram
Scientific Director
Avi Treves
Head of Research and Development
Noam Mizrahi
Lab Manager
Zohar Pinhasi
Member Board Of Directors
Elli Yosef
Global Business Strategist
Arieh Warshel
Nobel Prize winner in chemistry, Board of Directors
Sidney Altman
Nobel Prize winner in chemistry, Board of Directors
Peter Schwarz
Advisory Board Member, President-Elect of the International Diabetes Federation
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue Engineering
Technologies
Materials & SubstancesImplantsBiologicalsCells
Target customers
Healthcare & Life SciencesHealthcareProvidersPatients
Business model
B2B2C
Highlights
1 PatentsVerified
Tags
bioconvergencediabetescell-therapybiological-therapyregenerative-medicinebiopharmaceuticalbiotechnologychronic-patientstreatments
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | betalintherapeutics.com |
|---|---|
| linkedin.com/company/10782073 | |
| facebook.com/Betalin.Therapeutics.Inc | |
| YouTube | youtube.com/channel/UCvGtq0FUKMyK6n0s1F4jZrA |
Identifiers & details
| Founded | 2015 |
|---|---|
| Employees (exact) | 12 |
| Offices | Ramat Gan |
Radar intelligence
Patents
| EPO | 2 |
|---|
Web history (Wayback)
| Domain | betalintherapeutics.com |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515274272 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2015-07-28 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 5 — other (1), shares_capital (1), annual_report (3) |
| Registered address | דרך מן קלמן 0 ירושלים |
Recent registry events
| Date | Event |
|---|---|
| 2025-08-28 | שינוי בתקנון |
| 2025-08-24 | הקצאת מניות |
| 2026-07-13 | דו~ח שנתי-הסרת בעל תפקיד |
| 2026-07-13 | דו~ח שנתי-הסרת דירקטור |
| 2026-07-13 | דו~ח שנתי-הוספת דירקטור |